-
1
-
-
79960299888
-
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy
-
Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, Morton KE, Laurencot CM, Steinberg SM, White DE, Dudley ME. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res 2011, 17:4550-4557.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 4550-4557
-
-
Rosenberg, S.A.1
Yang, J.C.2
Sherry, R.M.3
Kammula, U.S.4
Hughes, M.S.5
Phan, G.Q.6
Citrin, D.E.7
Restifo, N.P.8
Robbins, P.F.9
Wunderlich, J.R.10
Morton, K.E.11
Laurencot, C.M.12
Steinberg, S.M.13
White, D.E.14
Dudley, M.E.15
-
2
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010, 363:711-723.
-
(2010)
N Engl J Med
, vol.363
, pp. 711-723
-
-
Hodi, F.S.1
O'Day, S.J.2
McDermott, D.F.3
Weber, R.W.4
Sosman, J.A.5
Haanen, J.B.6
Gonzalez, R.7
Robert, C.8
Schadendorf, D.9
Hassel, J.C.10
Akerley, W.11
van den Eertwegh, A.J.12
Lutzky, J.13
Lorigan, P.14
Vaubel, J.M.15
Linette, G.P.16
Hogg, D.17
Ottensmeier, C.H.18
Lebbé, C.19
Peschel, C.20
Quirt, I.21
Clark, J.I.22
Wolchok, J.D.23
Weber, J.S.24
Tian, J.25
Yellin, M.J.26
Nichol, G.M.27
Hoos, A.28
Urba, W.J.29
more..
-
3
-
-
84862859820
-
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
-
Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, Leming PD, Spigel DR, Antonia SJ, Horn L, Drake CG, Pardoll DM, Chen L, Sharfman WH, Anders RA, Taube JM, McMiller TL, Xu H, Korman AJ, Jure-Kunkel M, Agrawal S, McDonald D, Kollia GD, Gupta A, Wigginton JM, Sznol M. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012, 366:2443-2454.
-
(2012)
N Engl J Med
, vol.366
, pp. 2443-2454
-
-
Topalian, S.L.1
Hodi, F.S.2
Brahmer, J.R.3
Gettinger, S.N.4
Smith, D.C.5
McDermott, D.F.6
Powderly, J.D.7
Carvajal, R.D.8
Sosman, J.A.9
Atkins, M.B.10
Leming, P.D.11
Spigel, D.R.12
Antonia, S.J.13
Horn, L.14
Drake, C.G.15
Pardoll, D.M.16
Chen, L.17
Sharfman, W.H.18
Anders, R.A.19
Taube, J.M.20
McMiller, T.L.21
Xu, H.22
Korman, A.J.23
Jure-Kunkel, M.24
Agrawal, S.25
McDonald, D.26
Kollia, G.D.27
Gupta, A.28
Wigginton, J.M.29
Sznol, M.30
more..
-
4
-
-
84879759020
-
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma
-
Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, Wolchok JD, Hersey P, Joseph RW, Weber JS, Dronca R, Gangadhar TC, Patnaik A, Zarour H, Joshua AM, Gergich K, Elassaiss-Schaap J, Algazi A, Mateus C, Boasberg P, Tumeh PC, Chmielowski B, Ebbinghaus SW, Li XN, Kang SP, Ribas A. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med 2013, 369:134-144.
-
(2013)
N Engl J Med
, vol.369
, pp. 134-144
-
-
Hamid, O.1
Robert, C.2
Daud, A.3
Hodi, F.S.4
Hwu, W.J.5
Kefford, R.6
Wolchok, J.D.7
Hersey, P.8
Joseph, R.W.9
Weber, J.S.10
Dronca, R.11
Gangadhar, T.C.12
Patnaik, A.13
Zarour, H.14
Joshua, A.M.15
Gergich, K.16
Elassaiss-Schaap, J.17
Algazi, A.18
Mateus, C.19
Boasberg, P.20
Tumeh, P.C.21
Chmielowski, B.22
Ebbinghaus, S.W.23
Li, X.N.24
Kang, S.P.25
Ribas, A.26
more..
-
5
-
-
20044363610
-
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells
-
Antony PA, Piccirillo CA, Akpinarli A, Finkelstein SE, Speiss PJ, Surman DR, Palmer DC, Chan CC, Klebanoff CA, Overwijk WW, Rosenberg SA, Restifo NP. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol 2005, 174:2591-2601.
-
(2005)
J Immunol
, vol.174
, pp. 2591-2601
-
-
Antony, P.A.1
Piccirillo, C.A.2
Akpinarli, A.3
Finkelstein, S.E.4
Speiss, P.J.5
Surman, D.R.6
Palmer, D.C.7
Chan, C.C.8
Klebanoff, C.A.9
Overwijk, W.W.10
Rosenberg, S.A.11
Restifo, N.P.12
-
6
-
-
25844484607
-
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
-
Gattinoni L, Finkelstein SE, Klebanoff CA, Antony PA, Palmer DC, Spiess PJ, Hwang LN, Yu Z, Wrzesinski C, Heimann DM, Surh CD, Rosenberg SA, Restifo NP. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med 2005, 202:907-912.
-
(2005)
J Exp Med
, vol.202
, pp. 907-912
-
-
Gattinoni, L.1
Finkelstein, S.E.2
Klebanoff, C.A.3
Antony, P.A.4
Palmer, D.C.5
Spiess, P.J.6
Hwang, L.N.7
Yu, Z.8
Wrzesinski, C.9
Heimann, D.M.10
Surh, C.D.11
Rosenberg, S.A.12
Restifo, N.P.13
-
7
-
-
34547686398
-
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling
-
Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, Palmer DC, Boni A, Muranski P, Yu Z, Gattinoni L, Antony PA, Rosenberg SA, Restifo NP. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest 2007, 117:2197-2204.
-
(2007)
J Clin Invest
, vol.117
, pp. 2197-2204
-
-
Paulos, C.M.1
Wrzesinski, C.2
Kaiser, A.3
Hinrichs, C.S.4
Chieppa, M.5
Cassard, L.6
Palmer, D.C.7
Boni, A.8
Muranski, P.9
Yu, Z.10
Gattinoni, L.11
Antony, P.A.12
Rosenberg, S.A.13
Restifo, N.P.14
-
8
-
-
84888059687
-
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide
-
Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther PL, Eberl G, Bérard M, Ecobichon C, Clermont D, Bizet C, Gaboriau-Routhiau V, Cerf-Bensussan N, Opolon P, Yessaad N, Vivier E, Ryffel B, Elson CO, Doré J, Kroemer G, Lepage P, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013, 342:971-976.
-
(2013)
Science
, vol.342
, pp. 971-976
-
-
Viaud, S.1
Saccheri, F.2
Mignot, G.3
Yamazaki, T.4
Daillere, R.5
Hannani, D.6
Enot, D.P.7
Pfirschke, C.8
Engblom, C.9
Pittet, M.J.10
Schlitzer, A.11
Ginhoux, F.12
Apetoh, L.13
Chachaty, E.14
Woerther, P.L.15
Eberl, G.16
Bérard, M.17
Ecobichon, C.18
Clermont, D.19
Bizet, C.20
Gaboriau-Routhiau, V.21
Cerf-Bensussan, N.22
Opolon, P.23
Yessaad, N.24
Vivier, E.25
Ryffel, B.26
Elson, C.O.27
Doré, J.28
Kroemer, G.29
Lepage, P.30
more..
-
9
-
-
34247638961
-
Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma
-
Appay V, Voelter V, Rufer N, Reynard S, Jandus C, Gasparini D, Lienard D, Speiser DE, Schneider P, Cerottini JC, Romero P, Leyvraz S. Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma. J Immunother 2007, 30:240-250.
-
(2007)
J Immunother
, vol.30
, pp. 240-250
-
-
Appay, V.1
Voelter, V.2
Rufer, N.3
Reynard, S.4
Jandus, C.5
Gasparini, D.6
Lienard, D.7
Speiser, D.E.8
Schneider, P.9
Cerottini, J.C.10
Romero, P.11
Leyvraz, S.12
-
10
-
-
77955174496
-
Impact of 3 different short-term chemotherapy regimens on lymphocyte-depletion and reconstitution in melanoma patients
-
Laurent J, Speiser DE, Appay V, Touvrey C, Vicari M, Papaioannou A, Canellini G, Rimoldi D, Rufer N, Romero P, Leyvraz S, Voelter V. Impact of 3 different short-term chemotherapy regimens on lymphocyte-depletion and reconstitution in melanoma patients. J Immunother 2010, 33:723-734.
-
(2010)
J Immunother
, vol.33
, pp. 723-734
-
-
Laurent, J.1
Speiser, D.E.2
Appay, V.3
Touvrey, C.4
Vicari, M.5
Papaioannou, A.6
Canellini, G.7
Rimoldi, D.8
Rufer, N.9
Romero, P.10
Leyvraz, S.11
Voelter, V.12
-
11
-
-
14644390867
-
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909
-
Speiser DE, Lienard D, Rufer N, Rubio-Godoy V, Rimoldi D, Lejeune F, Krieg AM, Cerottini JC, Romero P. Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J Clin Invest 2005, 115:739-746.
-
(2005)
J Clin Invest
, vol.115
, pp. 739-746
-
-
Speiser, D.E.1
Lienard, D.2
Rufer, N.3
Rubio-Godoy, V.4
Rimoldi, D.5
Lejeune, F.6
Krieg, A.M.7
Cerottini, J.C.8
Romero, P.9
-
12
-
-
0344440962
-
LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination
-
Triebel F. LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination. Trends Immunol 2003, 24:619-622.
-
(2003)
Trends Immunol
, vol.24
, pp. 619-622
-
-
Triebel, F.1
-
13
-
-
33645842230
-
A soluble lymphocyte activation gene-3 (sLAG-3) protein as a prognostic factor in human breast cancer expressing estrogen or progesterone receptors
-
Triebel F, Hacene K, Pichon MF. A soluble lymphocyte activation gene-3 (sLAG-3) protein as a prognostic factor in human breast cancer expressing estrogen or progesterone receptors. Cancer Lett 2006, 235:147-153.
-
(2006)
Cancer Lett
, vol.235
, pp. 147-153
-
-
Triebel, F.1
Hacene, K.2
Pichon, M.F.3
-
14
-
-
0037090060
-
Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223)
-
Andreae S, Piras F, Burdin N, Triebel F. Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223). J Immunol 2002, 168:3874-3880.
-
(2002)
J Immunol
, vol.168
, pp. 3874-3880
-
-
Andreae, S.1
Piras, F.2
Burdin, N.3
Triebel, F.4
-
15
-
-
0034114926
-
A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens
-
El Mir S, Triebel F. A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens. J Immunol 2000, 164:5583-5589.
-
(2000)
J Immunol
, vol.164
, pp. 5583-5589
-
-
El Mir, S.1
Triebel, F.2
-
16
-
-
0032711858
-
Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses
-
Prigent P, El Mir S, Dreano M, Triebel F. Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses. Eur J Immunol 1999, 29:3867-3876.
-
(1999)
Eur J Immunol
, vol.29
, pp. 3867-3876
-
-
Prigent, P.1
El Mir, S.2
Dreano, M.3
Triebel, F.4
-
17
-
-
0037435889
-
MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells
-
Buisson S, Triebel F. MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells. Vaccine 2003, 21:862-868.
-
(2003)
Vaccine
, vol.21
, pp. 862-868
-
-
Buisson, S.1
Triebel, F.2
-
18
-
-
33646235175
-
Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity
-
Casati C, Camisaschi C, Rini F, Arienti F, Rivoltini L, Triebel F, Parmiani G, Castelli C. Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity. Cancer Res 2006, 66:4450-4460.
-
(2006)
Cancer Res
, vol.66
, pp. 4450-4460
-
-
Casati, C.1
Camisaschi, C.2
Rini, F.3
Arienti, F.4
Rivoltini, L.5
Triebel, F.6
Parmiani, G.7
Castelli, C.8
-
19
-
-
77958051699
-
Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients
-
Speiser DE, Schwarz K, Baumgaertner P, Manolova V, Devevre E, Sterry W, Walden P, Zippelius A, Conzett KB, Senti G, Voelter V, Cerottini JP, Guggisberg D, Willers J, Geldhof C, Romero P, Kündig T, Knuth A, Dummer R, Trefzer U, Bachmann MF. Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients. J Immunother 2010, 33:848-858.
-
(2010)
J Immunother
, vol.33
, pp. 848-858
-
-
Speiser, D.E.1
Schwarz, K.2
Baumgaertner, P.3
Manolova, V.4
Devevre, E.5
Sterry, W.6
Walden, P.7
Zippelius, A.8
Conzett, K.B.9
Senti, G.10
Voelter, V.11
Cerottini, J.P.12
Guggisberg, D.13
Willers, J.14
Geldhof, C.15
Romero, P.16
Kündig, T.17
Knuth, A.18
Dummer, R.19
Trefzer, U.20
Bachmann, M.F.21
more..
-
20
-
-
63149122367
-
Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure
-
Harari A, Enders FB, Cellerai C, Bart PA, Pantaleo G. Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure. J Virol 2009, 83:2862-2871.
-
(2009)
J Virol
, vol.83
, pp. 2862-2871
-
-
Harari, A.1
Enders, F.B.2
Cellerai, C.3
Bart, P.A.4
Pantaleo, G.5
-
21
-
-
79251515158
-
SPICE: Exploration and analysis of post-cytometric complex multivariate datasets
-
Roederer M, Nozzi JL, Nason MC. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 2011, 79A:167-174.
-
(2011)
Cytometry A
, vol.79 A
, pp. 167-174
-
-
Roederer, M.1
Nozzi, J.L.2
Nason, M.C.3
-
22
-
-
79952449129
-
Dominant TNF-alpha+Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease
-
Harari A, Rozot V, Enders FB, Perreau M, Stalder JM, Nicod LP, Cavassini M, Calandra T, Blanchet CL, Jaton K, Faouzi M, Day CL, Hanekom WA, Bart PA, Pantaleo G. Dominant TNF-alpha+Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 2011, 17:372-376.
-
(2011)
Nat Med
, vol.17
, pp. 372-376
-
-
Harari, A.1
Rozot, V.2
Enders, F.B.3
Perreau, M.4
Stalder, J.M.5
Nicod, L.P.6
Cavassini, M.7
Calandra, T.8
Blanchet, C.L.9
Jaton, K.10
Faouzi, M.11
Day, C.L.12
Hanekom, W.A.13
Bart, P.A.14
Pantaleo, G.15
-
23
-
-
84883757712
-
Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells
-
Viganò S, Enders FB, Miconnet I, Cellerai C, Savoye AL, Rozot V, Perreau M, Faouzi M, Ohmiti K, Cavassini M, Bart PA, Pantaleo G, Harari A. Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells. PLoS Pathog 2013, 9:e1003423.
-
(2013)
PLoS Pathog
, vol.9
-
-
Viganò, S.1
Enders, F.B.2
Miconnet, I.3
Cellerai, C.4
Savoye, A.L.5
Rozot, V.6
Perreau, M.7
Faouzi, M.8
Ohmiti, K.9
Cavassini, M.10
Bart, P.A.11
Pantaleo, G.12
Harari, A.13
-
24
-
-
33745091465
-
Functional signatures of protective antiviral T-cell immunity in human virus infections
-
Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, Pantaleo G. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 2006, 211:236-254.
-
(2006)
Immunol Rev
, vol.211
, pp. 236-254
-
-
Harari, A.1
Dutoit, V.2
Cellerai, C.3
Bart, P.A.4
Du Pasquier, R.A.5
Pantaleo, G.6
-
25
-
-
77950510141
-
Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R {alpha} (CD127) and perforin expression
-
Cellerai C, Perreau M, Rozot V, Enders FB, Pantaleo G, Harari A. Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R {alpha} (CD127) and perforin expression. J Virol 2010, 84:3868-3878.
-
(2010)
J Virol
, vol.84
, pp. 3868-3878
-
-
Cellerai, C.1
Perreau, M.2
Rozot, V.3
Enders, F.B.4
Pantaleo, G.5
Harari, A.6
-
26
-
-
84859720182
-
Positive and negative regulation of cellular immune responses in physiologic conditions and diseases
-
Vigano S, Perreau M, Pantaleo G, Harari A. Positive and negative regulation of cellular immune responses in physiologic conditions and diseases. Clin Dev Immunol 2012, 2012:485781.
-
(2012)
Clin Dev Immunol
, vol.2012
, pp. 485781
-
-
Vigano, S.1
Perreau, M.2
Pantaleo, G.3
Harari, A.4
-
27
-
-
70349669259
-
A phase I pharmacokinetic and biological correlative study of IMP321, a novel MHC class II agonist, in patients with advanced renal cell carcinoma
-
Brignone C, Escudier B, Grygar C, Marcu M, Triebel F. A phase I pharmacokinetic and biological correlative study of IMP321, a novel MHC class II agonist, in patients with advanced renal cell carcinoma. Clin Cancer Res 2009, 15:6225-6231.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 6225-6231
-
-
Brignone, C.1
Escudier, B.2
Grygar, C.3
Marcu, M.4
Triebel, F.5
-
28
-
-
35748957791
-
A soluble form of lymphocyte activation gene-3 (IMP321) induces activation of a large range of human effector cytotoxic cells
-
Brignone C, Grygar C, Marcu M, Schakel K, Triebel F. A soluble form of lymphocyte activation gene-3 (IMP321) induces activation of a large range of human effector cytotoxic cells. J Immunol 2007, 179:4202-4211.
-
(2007)
J Immunol
, vol.179
, pp. 4202-4211
-
-
Brignone, C.1
Grygar, C.2
Marcu, M.3
Schakel, K.4
Triebel, F.5
-
29
-
-
77955487541
-
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
-
Brignone C, Gutierrez M, Mefti F, Brain E, Jarcau R, Cvitkovic F, Bousetta N, Medioni J, Gligorov J, Grygar C, Marcu M, Triebel F. First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity. J Transl Med 2010, 8:71.
-
(2010)
J Transl Med
, vol.8
, pp. 71
-
-
Brignone, C.1
Gutierrez, M.2
Mefti, F.3
Brain, E.4
Jarcau, R.5
Cvitkovic, F.6
Bousetta, N.7
Medioni, J.8
Gligorov, J.9
Grygar, C.10
Marcu, M.11
Triebel, F.12
-
30
-
-
0033554726
-
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
-
Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
-
(1999)
Nature
, vol.401
, pp. 708-712
-
-
Sallusto, F.1
Lenig, D.2
Forster, R.3
Lipp, M.4
Lanzavecchia, A.5
-
31
-
-
64249096161
-
Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity
-
Kilinc MO, Gu T, Harden JL, Virtuoso LP, Egilmez NK. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity. J Immunol 2009, 182:4217-4225.
-
(2009)
J Immunol
, vol.182
, pp. 4217-4225
-
-
Kilinc, M.O.1
Gu, T.2
Harden, J.L.3
Virtuoso, L.P.4
Egilmez, N.K.5
-
32
-
-
79956077563
-
T cell exhaustion
-
Wherry EJ. T cell exhaustion. Nat Immunol 2011, 12:492-499.
-
(2011)
Nat Immunol
, vol.12
, pp. 492-499
-
-
Wherry, E.J.1
-
33
-
-
79957925314
-
Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients
-
Baitsch L, Baumgaertner P, Devevre E, Raghav SK, Legat A, Barba L, Wieckowski S, Bouzourene H, Deplancke B, Romero P, Rufer N, Speiser DE. Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients. J Clin Invest 2011, 121:2350-2360.
-
(2011)
J Clin Invest
, vol.121
, pp. 2350-2360
-
-
Baitsch, L.1
Baumgaertner, P.2
Devevre, E.3
Raghav, S.K.4
Legat, A.5
Barba, L.6
Wieckowski, S.7
Bouzourene, H.8
Deplancke, B.9
Romero, P.10
Rufer, N.11
Speiser, D.E.12
-
34
-
-
0033556322
-
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy
-
Zeh HJ, Perry-Lalley D, Dudley ME, Rosenberg SA, Yang JC. High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol 1999, 162:989-994.
-
(1999)
J Immunol
, vol.162
, pp. 989-994
-
-
Zeh, H.J.1
Perry-Lalley, D.2
Dudley, M.E.3
Rosenberg, S.A.4
Yang, J.C.5
-
35
-
-
63049108160
-
Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain
-
Kuball J, Hauptrock B, Malina V, Antunes E, Voss RH, Wolfl M, Strong R, Theobald M, Greenberg PD. Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain. J Exp Med 2009, 206:463-475.
-
(2009)
J Exp Med
, vol.206
, pp. 463-475
-
-
Kuball, J.1
Hauptrock, B.2
Malina, V.3
Antunes, E.4
Voss, R.H.5
Wolfl, M.6
Strong, R.7
Theobald, M.8
Greenberg, P.D.9
-
36
-
-
84862308565
-
Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose
-
Lovgren T, Baumgaertner P, Wieckowski S, Devevre E, Guillaume P, Luescher I, Rufer N, Speiser DE. Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose. Cancer Immunol Immunother 2012, 61:817-826.
-
(2012)
Cancer Immunol Immunother
, vol.61
, pp. 817-826
-
-
Lovgren, T.1
Baumgaertner, P.2
Wieckowski, S.3
Devevre, E.4
Guillaume, P.5
Luescher, I.6
Rufer, N.7
Speiser, D.E.8
-
37
-
-
67651231046
-
Immunotherapy: Vaccine trials in melanoma - time for reflection
-
Eggermont AM. Immunotherapy: Vaccine trials in melanoma - time for reflection. Nat Rev Clin Oncol 2009, 6:256-258.
-
(2009)
Nat Rev Clin Oncol
, vol.6
, pp. 256-258
-
-
Eggermont, A.M.1
-
38
-
-
4644324025
-
Cancer immunotherapy: moving beyond current vaccines
-
Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004, 10:909-915.
-
(2004)
Nat Med
, vol.10
, pp. 909-915
-
-
Rosenberg, S.A.1
Yang, J.C.2
Restifo, N.P.3
-
39
-
-
77954721060
-
Regulatory T cells in tumor immunity
-
Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int J Cancer 2010, 127:759-767.
-
(2010)
Int J Cancer
, vol.127
, pp. 759-767
-
-
Nishikawa, H.1
Sakaguchi, S.2
-
40
-
-
66249115337
-
The CD4 (+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells
-
Francois V, Ottaviani S, Renkvist N, Stockis J, Schuler G, Thielemans K, Colau D, Marchand M, Boon T, Lucas S, van der Bruggen P. The CD4 (+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells. Cancer Res 2009, 69:4335-4345.
-
(2009)
Cancer Res
, vol.69
, pp. 4335-4345
-
-
Francois, V.1
Ottaviani, S.2
Renkvist, N.3
Stockis, J.4
Schuler, G.5
Thielemans, K.6
Colau, D.7
Marchand, M.8
Boon, T.9
Lucas, S.10
van der Bruggen, P.11
-
41
-
-
84888347277
-
Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity
-
Perret R, Sierro SR, Botelho NK, Corgnac S, Donda A, Romero P. Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity. Cancer Res 2013, 73:6597-6608.
-
(2013)
Cancer Res
, vol.73
, pp. 6597-6608
-
-
Perret, R.1
Sierro, S.R.2
Botelho, N.K.3
Corgnac, S.4
Donda, A.5
Romero, P.6
-
42
-
-
33750940238
-
Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma
-
Mackensen A, Meidenbauer N, Vogl S, Laumer M, Berger J, Andreesen R. Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma. J Clin Oncol 2006, 24:5060-5069.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5060-5069
-
-
Mackensen, A.1
Meidenbauer, N.2
Vogl, S.3
Laumer, M.4
Berger, J.5
Andreesen, R.6
-
43
-
-
0037058993
-
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells
-
Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Nat'l Acad Sci U S A 2002, 99:16168-16173.
-
(2002)
Proc Nat'l Acad Sci U S A
, vol.99
, pp. 16168-16173
-
-
Yee, C.1
Thompson, J.A.2
Byrd, D.3
Riddell, S.R.4
Roche, P.5
Celis, E.6
Greenberg, P.D.7
-
44
-
-
84879045776
-
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
-
Kandalaft LE, Chiang CL, Tanyi J, Motz G, Balint K, Mick R, Coukos G. A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer. J Transl Med 2013, 11:149.
-
(2013)
J Transl Med
, vol.11
, pp. 149
-
-
Kandalaft, L.E.1
Chiang, C.L.2
Tanyi, J.3
Motz, G.4
Balint, K.5
Mick, R.6
Coukos, G.7
|